Profil
Dr. Rashmi H.
Barbhaiya is an Independent Non-Executive Director at OneSource Specialty Pharma Ltd. He is on the Board of Directors at OneSource Specialty Pharma Ltd. Dr. Barbhaiya was previously employed as a Vice President-Pharmaceutical Research Institute by Bristol Myers Squibb Co., a CEO, Director & Managing Director by Eurofins Peenya Resources Pvt Ltd., and a President-Research & Development by Ranbaxy Laboratories Ltd. He received his doctorate degree from the University of London.
Postes actifs de Rashmi Barbhaiya
| Sociétés | Poste | Début |
|---|---|---|
| ONESOURCE SPECIALTY PHARMA LIMITED | Directeur/Membre du Conseil | 17/05/2024 |
Anciens postes connus de Rashmi Barbhaiya
| Sociétés | Poste | Fin |
|---|---|---|
| RANBAXY LABORATORIES LIMITED | Directeur Technique/Scientifique/R&D | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Eurofins Advinus Ltd.
Eurofins Advinus Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical and agrochemical products | Directeur Général | - |
Formation de Rashmi Barbhaiya
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Ranbaxy Laboratories Ltd.
Ranbaxy Laboratories Ltd. Pharmaceuticals: GenericHealth Technology Engages in production and distribution of molecules and their combinations to therapies | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eurofins Advinus Ltd.
Eurofins Advinus Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical and agrochemical products | Health Technology |
OneSource Specialty Pharma Ltd.
OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
















